DiaGenic said this week that CEO Erik Christensen has resigned.
Christensen will "continue to provide consultative support to the company on partner interactions, licensing and other business activities," DiaGenic said in a statement.
Henrik Lund, chairman of the company's board, will serve as CEO until a replacement for Christensen is found. Ingrid Wiik, deputy chairman of the board, will act as chairman until the company's annual general meeting on June 5.
Christensen has been CEO of DiaGenic since 2007.
NanoString Technologies has appointed Joseph Beechem as senior vice president of research and development.
Beechem joins the company from Life Technologies, where he was most recently vice president; head of advanced sequencing; and head of global sequencing chemistry, biochemistry, and biophysics. Prior to that, he was chief technology officer of Life Technologies, chief scientific officer at Invitrogen (now part of Life Tech), and director of biosciences at Molecular Probes.
Prior to joining industry, Beechem was an associate professor at Vanderbilt University for 11 years. He holds a BS in chemistry and biology from Northern Kentucky University and a PhD in biophysics from Johns Hopkins University.